Allogene Therapeutics Presents Preclinical Data on Next Generation Cloak and Dagger Technologies at the Society for Immunotherapy of Cancer Annual Meeting

03.11.2023 - Cloak and Dagger Technologies Show Potential to Reduce Dependence on Standard Lymphodepletion and Enhance Performance of AlloCAR T CellsData from Preclinical Study of Cloak Technology Highlights Ability to Engineer Allogeneic Cells to Evade ... Seite 1

Related Keywords

San Diego ,California ,United States ,Zachary Roberts ,Dagger Technology ,Nasdaq ,Research Development ,Society For Immunotherapy Of Cancer ,Allogene Therapeutics Inc ,Dagger Technologies Show Potential ,Reduce Dependence ,Standard Lymphodepletion ,Enhance Performance ,Preclinical Study ,Cloak Technology Highlights Ability ,Engineer Allogeneic Cells ,Evade Detection ,Host Immune System ,Being Investigated ,Solid Tumors ,Enables Dual ,Selectively Eliminate ,Positive Tumor Cells ,Annual Meeting November ,Executive Vice President ,Chief Medical Officer ,Allogene Therapeutics Chart ,Llogene Therapeutics Kurs ,Llogene Therapeutics Aktie ,